Ecomat, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2019
January 23, 2020 at 02:03 pm
Share
Ecomat, Inc. announced earnings results for the second quarter ended December 31, 2019. For the second quarter, the company announced net loss was USD 19,789 compared to USD 20,376 a year ago. For the half year, net loss was USD 42,610 compared to USD 39,172 a year ago.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
ECOMAX, INC. 
